cypermethrin has been researched along with Parkinson Disease in 4 studies
cypermethrin : A carboxylic ester resulting from the formal condensation between 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid and the alcoholic hydroxy group of hydroxy(3-phenoxyphenyl)acetonitrile.
zeta-cypermethrin : A diastereoisomeric mixture comprising the isomeric pair (1R)-cis-(alphaS)- and (1S)-trans-(alphaR)-cypermethrin together with the isomeric pair (1S)-cis-(alphaS)- and (1S)-trans-(alphaS)-cypermethrin where the ratio between the isomeric pairs lies in the range 45:55 to 55:45.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The etiology of Parkinson's disease (PD) is highly complex and is still indefinable." | 1.91 | Dyshomeostasis of Iron and Its Transporter Proteins in Cypermethrin-Induced Parkinson's Disease. ( Katiyar, D; Patel, DK; Sachan, N; Singh, MP; Srikrishna, S; Tiwari, N, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sachan, N | 1 |
| Tiwari, N | 1 |
| Patel, DK | 3 |
| Katiyar, D | 1 |
| Srikrishna, S | 1 |
| Singh, MP | 3 |
| Mishra, AK | 1 |
| Mishra, S | 1 |
| Rajput, C | 1 |
| Ur Rasheed, MS | 1 |
| Mohammadi, H | 1 |
| Ghassemi-Barghi, N | 1 |
| Malakshah, O | 1 |
| Ashari, S | 1 |
| Agrawal, S | 1 |
| Dixit, A | 1 |
| Singh, A | 1 |
| Tripathi, P | 1 |
| Singh, D | 1 |
1 review available for cypermethrin and Parkinson Disease
| Article | Year |
|---|---|
Pyrethroid exposure and neurotoxicity: a mechanistic approach.
Topics: Antitoxins; Humans; Insecticides; Neurotoxicity Syndromes; NF-E2-Related Factor 2; Nitriles; Nuclear | 2019 |
3 other studies available for cypermethrin and Parkinson Disease
| Article | Year |
|---|---|
Dyshomeostasis of Iron and Its Transporter Proteins in Cypermethrin-Induced Parkinson's Disease.
Topics: Animals; Ceruloplasmin; Copper; Hepcidins; Humans; Iron; Magnesium; Molecular Docking Simulation; Pa | 2023 |
Cypermethrin Activates Autophagosome Formation Albeit Inhibits Autophagy Owing to Poor Lysosome Quality: Relevance to Parkinson's Disease.
Topics: Animals; Apoptosis; Autophagosomes; Autophagy; Humans; Lysosomes; Neurodegenerative Diseases; Parkin | 2018 |
Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism.
Topics: alpha-Synuclein; Animals; Corpus Striatum; Cyclosporine; Dopaminergic Neurons; Metalloporphyrins; Mi | 2015 |